stella
beta
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery — Stella
Recruiting
Back to Myocardial Injury trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(3 sites)
China
Duchess of Kent Children's Hospital at Sandy Bay, Hong Kong, Hong Kong SAR
Queen Mary Hospital, Hong Kong, Hong Kong SAR
Tung Wah Hospital, Hong Kong, Hong Kong SAR
View full record on ClinicalTrials.gov